|
Talis Biomedical Corporation (NASDAQ: TLIS) |
|
Talis Biomedical Corporation
TLIS's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Talis Biomedical's sales fell
in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1892
Laboratory Analytical Instruments industry recorded
deterioration of revenues by -2.38 %
Talis Biomedical net loss decreased from $-15 millions, to $-9 millions in II. Quarter 2024,
• More on TLIS's Growth
|
|
Talis Biomedical realized a net loss in trailing twelve months.
Talis Biomedical realized cash reduction of $ -22.01 per share in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
9.26 |
PE TTM
|
|
Company's Price to Sales ratio is at 7.59.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 3.81.
• More on TLIS's Valuation
|
|
|
|
|
Talis Biomedical realized net loss in trailing twelve months.
Talis Biomedical realized cash outflow of $ -22.01per share in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
9.26 |
PE TTM
|
|
Company's Price to Sales ratio is at 7.59.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 3.81.
Talis Biomedical Price to Book Ratio is at 0.06 lower than Industry Avg. of 205.09. and higher than S&P 500 Avg. of 0.01
• More on TLIS's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com